Furthermore, individuals with schizophrenia who are receiving treatment with first- and second-generation antipsychotics may gain weight due to genes like leptin (LEP) and cannabinoid receptor 1 (CNR1) (Tiwari et al. 2010). This evidence concerns the gene LEP and schizophrenia.